Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules

Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules

Abstract Because of the strain-dependent effect and the lack of simultaneous in vitro test with limited clinical data on Lacticaseibacillus rhamnosus L34 (L34) isolated from the Thai population, L34 was tested and compared with L. rhamnosus GG (LGG). The before and after test using L34 and a randomi...

Full description

Saved in:
Bibliographic Details
Main Authors: Asada Leelahavanichkul, Pornpimol Phuengmaung, Thansita Bhunyakarnjanarat, Warerat Kaewduangduen, Pimmada Boonnaj, Pichanan Tengamnuay, Wiwat Chancharoenthana, Somkanya Tungsanga, Suwasin Udomkarnjananun, Somying Tumwasorn
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Lacticaseibacillus rhamnosus
Probiotics
Gut-derived uremic toxins
Gut leakage
Chronic kidney disease
Online Access:https://doi.org/10.1038/s41598-025-12768-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-12768-z

Similar Items